• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效测量和分解. 中的高阶药物相互作用

Efficient measurement and factorization of high-order drug interactions in .

机构信息

Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111, USA.

Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Sci Adv. 2017 Oct 11;3(10):e1701881. doi: 10.1126/sciadv.1701881. eCollection 2017 Oct.

DOI:10.1126/sciadv.1701881
PMID:29026882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5636204/
Abstract

Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of -way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against . Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models.

摘要

三联或更多种药物的联合应用被用于治疗多种疾病,包括结核病。因此,了解药物相互作用的协同或拮抗作用如何影响联合治疗的疗效非常重要。然而,由于缺乏有效的测量方法和用于分析和解释的理论框架,我们对高阶药物相互作用的了解受到限制。我们开发了一种有效的实验采样和评分方法[三向药物相互作用的对角线测量(DiaMOND)],以测量任意数量药物组合的药物相互作用。DiaMOND 为棋盘检测提供了一种有效的替代方法,棋盘检测常用于测量药物相互作用。我们建立了一个几何框架,将高阶药物相互作用分解为较低阶的组成部分,从而为如何使用较低阶测量来预测高阶相互作用建立了一个路线图。我们的框架是一个用于高阶药物相互作用的广义 Loewe 加性模型。使用 DiaMOND,我们鉴定和分析了针对 的协同和拮抗抗生素组合。DiaMOND 对高阶药物相互作用的高效测量和分解广泛适用于其他细胞类型和疾病模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/61baa87cc5e9/1701881-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/7ccc57d9f876/1701881-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/bf2e5acc1715/1701881-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/d8d5fbd79a05/1701881-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/61baa87cc5e9/1701881-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/7ccc57d9f876/1701881-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/bf2e5acc1715/1701881-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/d8d5fbd79a05/1701881-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/125a/5636204/61baa87cc5e9/1701881-F4.jpg

相似文献

1
Efficient measurement and factorization of high-order drug interactions in .高效测量和分解. 中的高阶药物相互作用
Sci Adv. 2017 Oct 11;3(10):e1701881. doi: 10.1126/sciadv.1701881. eCollection 2017 Oct.
2
Efficient Measurement of Drug Interactions with DiaMOND (Diagonal Measurement of N-Way Drug Interactions).高效测量药物相互作用的 DiaMOND(对角测量多药物相互作用)方法。
Methods Mol Biol. 2021;2314:703-713. doi: 10.1007/978-1-0716-1460-0_30.
3
Design of high-order antibiotic combinations against M. tuberculosis by ranking and exclusion.通过排序和排除设计针对结核分枝杆菌的高阶抗生素组合。
Sci Rep. 2019 Aug 15;9(1):11876. doi: 10.1038/s41598-019-48410-y.
4
Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.快速检测分枝杆菌药物相互作用的棋盘微量肉汤显色法。
Tuberculosis (Edinb). 2013 Nov;93(6):660-3. doi: 10.1016/j.tube.2013.09.001. Epub 2013 Sep 13.
5
The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.时间杀菌动力学测定作为评估抗结核药物活性的临床前建模框架一部分的作用。
Tuberculosis (Edinb). 2017 Jul;105:80-85. doi: 10.1016/j.tube.2017.04.010. Epub 2017 Apr 27.
6
Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.两种抗结核药物组合对结核分枝杆菌的协同作用。
Tuberculosis (Edinb). 2012 May;92(3):260-3. doi: 10.1016/j.tube.2012.01.005. Epub 2012 Feb 16.
7
In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.左氧氟沙星、莫西沙星和 UB-8902 联合氯法齐明和贝达喹啉对结核分枝杆菌的体外活性。
Int J Antimicrob Agents. 2015 Nov;46(5):582-5. doi: 10.1016/j.ijantimicag.2015.08.004. Epub 2015 Sep 7.
8
Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.利奈唑胺与莫西沙星治疗儿童结核病的浓度依赖性协同和拮抗作用:活力组合
Clin Infect Dis. 2016 Nov 1;63(suppl 3):S88-S94. doi: 10.1093/cid/ciw473.
9
Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design Recommendations.评估药效学相互作用的分析方法比较,包括设计建议。
AAPS J. 2018 Jun 21;20(4):77. doi: 10.1208/s12248-018-0239-0.
10
Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.Casiopeínas®铜配合物与抗结核药物联合使用对结核分枝杆菌的潜力。
Chemotherapy. 2016;61(5):249-55. doi: 10.1159/000443496. Epub 2016 Mar 8.

引用本文的文献

1
Clinical outcomes of flomoxef versus cefmetazole in hospitalized patients with urinary tract infections: combined retrospective analyses of two real-world databases and in vitro data.氟氧头孢与头孢美唑治疗住院尿路感染患者的临床结局:两项真实世界数据库及体外数据的联合回顾性分析
BMC Med. 2025 Jul 1;23(1):396. doi: 10.1186/s12916-025-04130-x.
2
Evolutionarily divergent Mycobacterium tuberculosis CTP synthase filaments are under selective pressure.进化上不同的结核分枝杆菌CTP合酶细丝处于选择压力之下。
Nat Commun. 2025 Jul 1;16(1):5993. doi: 10.1038/s41467-025-60847-6.
3
Targeting de novo purine biosynthesis for tuberculosis treatment.

本文引用的文献

1
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.基于分子结构衍生描述符预测抗生素相互作用。
J Med Chem. 2017 May 11;60(9):3902-3912. doi: 10.1021/acs.jmedchem.7b00204. Epub 2017 Apr 27.
2
Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.肺结核中的浓度依赖性拮抗作用与培养转化
Clin Infect Dis. 2017 May 15;64(10):1350-1359. doi: 10.1093/cid/cix158.
3
Uncovering emergent interactions in three-way combinations of stressors.揭示应激源三元组合中的新出现的相互作用。
靶向从头嘌呤生物合成用于结核病治疗。
Nature. 2025 Jun 18. doi: 10.1038/s41586-025-09177-7.
4
Defining the mechanism of action of the nitrofuranyl piperazine HC2210 against Mycobacterium abscessus.确定硝基呋喃基哌嗪HC2210对脓肿分枝杆菌的作用机制。
NPJ Antimicrob Resist. 2025 Jun 14;3(1):55. doi: 10.1038/s44259-025-00124-0.
5
Pleomorphic effects of three small-molecule inhibitors on transcription elongation by RNA polymerase.三种小分子抑制剂对RNA聚合酶转录延伸的多形性影响。
bioRxiv. 2025 Feb 7:2025.02.07.637008. doi: 10.1101/2025.02.07.637008.
6
Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform.前瞻性地使用转化小鼠到人类的平台预测 BPaMZ Ⅱb/Ⅲ期临床试验结果。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0061524. doi: 10.1128/aac.00615-24. Epub 2024 Sep 17.
7
Identification of gene targets that potentiate the action of rifampicin on BCG.鉴定增强利福平对卡介苗作用的基因靶标。
Microbiology (Reading). 2024 Aug;170(8). doi: 10.1099/mic.0.001488.
8
Evolutionarily divergent CTP synthase filaments are under selective pressure.进化上不同的CTP合酶丝受到选择压力。
bioRxiv. 2024 Jul 25:2024.07.25.605180. doi: 10.1101/2024.07.25.605180.
9
Data-driven learning of structure augments quantitative prediction of biological responses.基于数据的结构学习增强了对生物响应的定量预测。
PLoS Comput Biol. 2024 Jun 3;20(6):e1012185. doi: 10.1371/journal.pcbi.1012185. eCollection 2024 Jun.
10
Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model responses.生长培养基在模拟反应的革兰氏阴性菌中检测药物相互作用的关键作用。
mBio. 2024 Mar 13;15(3):e0015924. doi: 10.1128/mbio.00159-24. Epub 2024 Feb 16.
J R Soc Interface. 2016 Dec;13(125). doi: 10.1098/rsif.2016.0800.
4
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.用于儿童药敏性结核病和耐多药结核病的法罗培南、利奈唑胺和莫西沙星治疗方案:银河系上的FLAME路径
Clin Infect Dis. 2016 Nov 1;63(suppl 3):S95-S101. doi: 10.1093/cid/ciw474.
5
Pairwise interactions and the battle against combinatorics in multidrug therapies.多药疗法中的成对相互作用与对抗组合复杂性的斗争
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10231-3. doi: 10.1073/pnas.1612365113. Epub 2016 Sep 1.
6
Prediction of multidimensional drug dose responses based on measurements of drug pairs.基于药物对测量结果的多维药物剂量反应预测
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10442-7. doi: 10.1073/pnas.1606301113. Epub 2016 Aug 25.
7
Turning the respiratory flexibility of Mycobacterium tuberculosis against itself.利用结核分枝杆菌的呼吸灵活性来对抗它自身。
Nat Commun. 2016 Aug 10;7:12393. doi: 10.1038/ncomms12393.
8
Chemogenomics and orthology-based design of antibiotic combination therapies.基于化学基因组学和直系同源性的抗生素联合疗法设计
Mol Syst Biol. 2016 May 24;12(5):872. doi: 10.15252/msb.20156777.
9
Multidrug evolutionary strategies to reverse antibiotic resistance.逆转抗生素耐药性的多药进化策略。
Science. 2016 Jan 1;351(6268):aad3292. doi: 10.1126/science.aad3292.
10
Treatment of Tuberculosis.结核病的治疗
N Engl J Med. 2015 Nov 26;373(22):2149-60. doi: 10.1056/NEJMra1413919.